Vaxxirna Launches to Advance Next-Generation Circular RNA Vaccines for Infectious Disease Prevention
Company's proprietary viRNA™ platform is designed to enable durable immune protection, thermostability, and patient-friendly vaccine delivery HOUSTON, TX, UNITED STATES, June 24, 2026 /EINPresswire.com/ -- Vaxxirna, Inc., a biotechnology …